About Robert Arch
Robert Arch is CEO & President at Immunophotonics.
Experience
This experience comes from Robert Arch's profile and from SEC filings. For roles taken from filings, the years are when the filings name Robert Arch in the role, so the role may have started earlier or lasted longer.
Immunophotonics, Inc. Current
CEO & President
President & Chief Executive Officer (2024 – Present)
2024 – Present · St. Louis, MO
Develops immune-stimulating treatments for people with solid-tumor cancers.
ON
OncoSec
President and CEO
2022 – 2023
RO
Roche
Research & Development Consultant
2021
EB
Elpiscience Biopharmaceuticals
Senior Vice President, Head of Research
2019 – 2021
NN
Novartis Institutes for BioMedical Research (NIBR)
Executive Director; Head, Liver Disease Program
2017 – 2019
TA
Takeda
Senior Director; Global Head of Liver Disease Research (2015 – 2017)
Director, Subleader Value Creation Alternatives (2013 – 2015)
2013 – 2017
GL
GlaxoSmithKline
Director
2012 – 2013
PF
Pfizer
Director
2006 – 2012
WL
Washington University School of Medicine in St. Louis
Assistant Professor of Medicine, Assistant Professor of Pathology & Immunology
2000 – 2006
WL
Washington University in St. Louis
Assistant Professor of Medicine, Pathology & Immunology
1999 – 2006
Key Colleagues at Startups
The people Robert Arch works with at each company, as listed on that company's latest Form D.
Immunophotonics, Inc. · Form D, Sep 4, 2026
MZ
Miguel Zubizarreta
Director
RL
Richard Levenson
Director
Luciano Alleruzzo
Co-founder & Director
Jonathan Knowles
Chairman
JH
Jacqueline Hess
Director
Wei Chen
Co-founder, Co-inventor & Director
Alexander Hurst
Chief Corporate Officer & General Counsel